60 Degree Pharma Receives U.S. FDA Approval for ARAKODA (tafenoquine) tablets for Treating Malaria

 60 Degree Pharma Receives U.S. FDA Approval for ARAKODA (tafenoquine) tablets for Treating Malaria

60 Degree Pharma Receives U.S. FDA Approval for ARAKODA (tafenoquine) tablets for Treating Malaria

Shots:

  •  Arakoda the first preventive antimicrobial drug approved by FDA is for patients aged ≥18yrs
  •  The combined efforts of US Army and 60 Degree Pharma(60P) involving over 21 clinical trials and over 3,100 trial subjects, lead Arakoda’s approval
  • Arakoda is approved first time after ~18yrs by FDA with its dosage once a week, marketed in 100mg tablets for oral use only                       

Click here to read full press release/ article | Ref: 60degreespharma | Image: Devex

Vartika Singh

Vartika Singh is a content writer who loves to write research articles and reports at PharmaShots. She has in-depth knowledge of the life sciences industry including the Pharma and Biotech sectors. Any articles written by her can be contacted at connect@pharmashots.com.

Related post